Vycor Medical Inc (VYCO): Operating Cash Flow
-$13.5K
Year ended 2025-12-31
$61.4K
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$13.5K | n/m | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $60.1K | +104.2% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $29.4K | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$217.0K | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $21.4K | n/m | 2023-04-14, From 2021-01-01 |
| 2020-12-31 | -$248.8K | n/m | 2022-04-13, From 2020-01-01 |
| 2019-12-31 | -$6.0K | n/c | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$260.3K | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$527.4K | n/m | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | -$496.9K | n/m | 2018-03-30, From 2016-01-01 |
| 2015-12-31 | -$1.17M | n/m | 2017-03-31, From 2015-01-01 |
| 2014-12-31 | -$2.70M | n/m | 2015-03-31, From 2014-01-01 |
| 2013-12-31 | -$758.4K | n/a | 2015-03-31, From 2013-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Vycor Medical Inc (VYCO) | 2025-12-31 | -$13.5K | n/m |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | -$53.19M | n/m |
| Femasys Inc (FEMY) | 2025-12-31 | -$18.69M | n/m |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $178.1K | +25.1% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | -$13.60M | n/m |
| OSR Health, Inc. (OSRH) | 2025-12-31 | -$4.33M | n/m |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | -$6.11M | n/m |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | -$10.97M | n/m |
| Nuo Therapeutics, Inc. (AURX) | 2025-12-31 | -$865.0K | n/m |
Compare VYCO, NONE., FEMY, USAQ side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗